Proceedings: The effects of ulcerogenic and ulcer-healing drugs on gastric mucus.
D000818:Animals; D002229:Carbenoxolone / Q000494:pharmacology*; D005752:Gastric Mucins / Q000096:biosynthesis*; D005753:Gastric Mucosa / Q000187:drug effects* / Q000378:metabolism; D006023:Glycoproteins / Q000096:biosynthesis; D006801:Humans; D007213:Indomethacin / Q000494:pharmacology*; D010653:Phenylbutazone / Q000494:pharmacology*; D051381:Rats; D013148:Spironolactone / Q000494:pharmacology*; D014315:Triterpenes / Q000494:pharmacology*
D005752:Gastric Mucins; D006023:Glycoproteins; D014315:Triterpenes; D013148:Spironolactone; D010653:Phenylbutazone; D002229:Carbenoxolone; D007213:Indomethacin